Is Now the Right Time to Buy Novavax Stock?
One of the best-performing biotech stocks so far this year is Novavax (NASDAQ: NVAX). The company wasn't particularly well-known going into 2020, but its stock price has risen by an astonishing 3,850% this year. Given its status as a promising COVID-19 vaccine developer -- one of many out there -- it's not surprising that the price has shot up so much so fast.
Just recently, Novavax released new clinical data surrounding its promising vaccine candidate, news that sent the stock jumping even further. With the company's prospects looking better than ever, should on-the-fence investors get in on this biotech company before shares rise even more? Let's find out.
Image source: Getty Images.
Source Fool.com
